Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma

Cancer Research

Volumn 63, Issue 16, 2003, Pages 5159-5164

  Ishibashi, Yoshio ^a   Hanyu, Nobuyoshi ^a   Nakada, Koji ^a   Suzuki, Yutaka ^a   Yamamoto, Takashi ^a   Yanaga, Katsuhiko ^a   Ohkawa, Kiyoshi ^a   Hashimoto, Noriko ^b   Nakajima, Toshiharu ^b   Saito, Hirohisa ^b   Matsushima, Masato ^a   Urashima, Mitsuyoshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER RECURRENCE; CELL CYCLE; CLINICAL ARTICLE; DNA FINGERPRINTING; DNA MICROARRAY; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 0042014325     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kelsen, D. P., Ginsberg, R., Pajak, T. F., Sheahan, D. G., Gunderson, L., Mortimer. J., Estes, N., Haller, D. G., Ajani, J., Kocha, W., Minsky, B. D., and Roth, J. A. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N., Engl., J., Med., 339: 1979-1984, 1998.
2. Sobin, L. H., and Wittekind, C. TNM classification of malignant tumors, Ed. 5. New York: Wiley-Liss. 1997.
3. Sturm, I., Petrowsky, H., Volz, R., Lorenz, M., Radetzki, S., Hillebrand, T., Wolff, G., Hauptmann, S., Dorken, B., and Daniel, P. T. Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis. J., Clin., Oncol., 19: 2272-2281, 2001.
4. Ahr, A., Karn, T., Solbach, C., Seiter, T., Strebhardt, K., Holtrich, U., and Kaufmann, M. Identification of high risk breast-cancer patients by gene expression profiling. Lancet, 359: 131-132, 2002.
5. Xu, X-R., Huang, J., Xu, Z-G., Qian, B. Z., Zhu, Z. D., Yan, Q., Cai, T., Zhang, X., Xiao, H. S., Qu, J., Liu, F., Huang, Q. H., Cheng, Z. H., Li, N. G., Du, J. J., Hu, W., Shen, K. T., Lu, G., Fu, G., Zhong, M., Xu, S. H., Gu, W. Y., Huang, W., Zhao. X. T., Hu, G. X., Gu, J. R., Chen, Z., and Han, Z. G. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profile of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc., Natl., Acad., Sci., USA, 18: 15089-15094, 2001.
6. Moustafa, A-E., Alaoui-Jamali, M. A., Batist, G., Hernandez-Perez, M., Serruya, C., Alpert, L., Black, M. J., Sladek, R., and Foulkes, W. D. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal and squamous carcinoma cells. Oncogene, 21: 2634-2640, 2002.
7. Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., and Chinnaiyan, A. M. Delineation of prognostic biomarkers in prostate cancer. Nature (Lond.), 412: 822-826, 2001.
8. Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Kallioniemi, O. P., Wilfond, B., Borg, A., and Trent, J. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med., 344: 539-548, 2001.
9. Nielsen, T. O., West, R. B., Linn, S. C., Alter, O., Knowling, M. A., O'Connell, J. X., Zhu, S., Fero, M., Sherlock, G., Pollack, J. R., Brown, P. O., Botstein, D., and van de Rijn, M. Molecular characterization of soft tissue tumours: a gene expression study. Lancet, 359: 1301-1307, 2002.
10. Khan, J., Wei, J. S., Ringner, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., Peterson, C., and Meltzer, P. S. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med., 7: 673-679, 2001.
11. Shipp, M. A., Ross, K. N., Tamayo, P., Weng, A. P., Kutok, J. L., Aguiar, R. C., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G. S., Ray, T. S., Koval, M. A., Last, K. W., Norton, A., Lister, T. A., Mesirov, J., Neuberg, D. S., Lander, E. S., Aster, J. C., and Golub, T. R. Diffuse large B-cell lymphoma outcome prediction by gene expression profiling and supervised machine learning. Nat. Med., 8: 68-74, 2002.
12. Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y., Goumnerova, L. C., Black, P. M., Lau, C., Allen, J. C., Zagzag, D., Olson, J. M., Curran, T., Wetmore, C., Biegel, J. A., Poggio, T., Mukherjee, S., Rifkin, R., Califano, A., Stoloxitzky, G., Louis, D. N., Mesirov, J. P., Lander, E. S., and Golub, T. R. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature (Lond.), 415: 436-442, 2002.
13. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., and Lander, E. S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Wash. DC), 286: 531-537, 1999.
14. van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.), 415: 530-536, 2002.
15. Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Yang, L., Wilson, W. H., Jaffe, E. S., Simon, R., Klausner, R. D., Powell, J., Duffey, P. L., Longo, D. L., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Montserrat, E., Lopez-Guillermo, A., Grogan, T. M., Miller, T. P., LeBlanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T., and Staudt, L. M. Lymphoma/Leukemia Molecular Profiling Project. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med., 346: 1937-1947, 2002.
16. Zhang, H., Yu, C. Y., Singer, B., and Xiong, M. Recursive partitioning for tumor classification with gene expression microarray data. Proc. Natl. Acad. Sci. USA., 98: 6730-6735, 2001.
17. Prakash, K., Pirozzi, G., Elashoff, M., Munger, W., Waga, I., Dhir, R., Kakehi, Y., and Getzenberg, R. H. Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc. Natl. Acad. Sci. USA, 99: 7598-7603, 2002.
18. Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., Loda, M., Weber, G., Mark, E. J., Lander, E. S., Wong, W., Johnson, B. E., Golub, T. R., Sugarbaker, D. J., and Meyerson, M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA, 98: 13790-13802, 2001.
19. Chang, F., Syrjanen, S., Shen, Q., Cintorino, M., Santopietro, R., Tosi, P., and Syrjanen, K. Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China. Anticancer Res., 20: 3935-3940, 2000.
20. Toh, Y., Kuwano, H., Tanaka, S., Baba, K., Matsuda, H., Sugimachi, K., and Mori, R. Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer (Phila.), 70: 2234-2238, 1992.
21. Matsha, T., Erasmus, R., Kafuko, A. B., Mugwanya, D., Stepien, A., and Parker, M. I. Human papillomavirus associated with esophageal cancer. J. Clin. Pathol., 55: 587-590, 2002.
22. Borysiewicz, L. K., Fiander, A., Nimako, M., Man, S., Wilkinson, G. W., Westmoreland, D., Evans, A. S., Adams, M., Stacey, S. N., Boursnell, M. E., Rutherford, E., Hickling, J. K., and Inglis, S. C. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet, 347: 1523-1527, 1996.
23. Kihara, C., Tsunoda, T., Tanaka, T., Yamana, H., Furukawa, Y., Ono, K., Kitahara, O., Zembutsu, H., Yanagawa, R., Hirata, K., Takagi, T., and Nakamura, Y. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy. Cancer Res., 61: 6474-6485, 2001.
24. Huang, P., Feng, L., Oldham, E. A., Keating, M. J., and Plunkett, W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature (Lond.), 407: 390-395, 2000.
25. Spataro, V., Norbury, C., and Harris, A. L. The ubiquitin-proteasome pathway in cancer. Br. J. Cancer, 77: 448-455, 1998.
26. Toppmeyer, D., Seidman, A. D., Pollak, M., Russell, C., Tkaczuk, K., Verma, S., Overmoyer, B., Garg, V., Ette, E., Harding, M. W., and Demetri, G. D. Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel. Clin. Cancer Res., 8: 670-678, 2002.
27. Zhao, H. J., Hosoi, Y., Miyachi, H., Ishii, K., Yoshida, M., Nemoto, K., Takai, Y., Yamada, S., Suzuki, N., and Ono, T. DNA-dependent protein kinase activity correlates with Ku70 expression and radiation sensitivity in esophageal cancer cell lines. Clin. Cancer. Res., 6: 1073-1078, 2000.
28. Toh, Y., Kuwano, H., Mori, M., Nicolson, G. L., and Sigimachi, K. Overexpression of metastasis-associated MTAI mRNA in invasive esophageal carcinomas. Br. J. Cancer, 79: 1723-1726, 1999.